Database for the Assessment of Efficacy and Safety of BPH Treatment
Database for the Assessment of Efficacy and Safety of BPH Treatment
This registry study aims to collect data on efficacy and safety of different treatments of
 benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign
 prostatic hyperplasia (BPH-LUTS).
This registry study aims to collect data on efficacy and safety of different treatments of
 benign prostatic enlargement (BPE) and lower urinary tract symptoms associated with benign
 prostatic hyperplasia (BPH-LUTS).

 Clinical, patient reported and imaging data that are assessed in clinical routine will be
 prospectively collected. All patients that are treated for BPE / BPH-LUTS at our institution
 will be included if they provide written informed consent.

 This registry enables us to compare novel treatment option (e.g. prostatic artery
 embolization; PAE) to established interventions (e.g., TURP, HoLEP, open prostatectomy,
 ThuLEP, Thulium laser vaporization, TUIP) regarding safety and efficacy.
Inclusion Criteria:

 -  All patients treated for BPH / LUTS / prostatic obstruction at the urological
 department of KSSG

 -  Patient age ≥ 18 years

 -  Informed consent provided

 Exclusion Criteria:

 -Cognitive impairment not allowing Informed Consent or adequate data assessment.